Born of necessity. Raised by determination.
Driven to mind the gap.

The MPNRF plays a uniquely independent role in the expanding global MPN community, convening academia, industry, patients, advocates and regulatory agencies; catalyzing and funding collaborative research across institutions and scientific disciplines. The goal: to discover better treatments and improve quality of life for people living with essential thrombocythemia, polycythemia vera and myelofibrosis.

The MPN Advocates Network is proud to share the voices of leading MPN researchers, clinicians, advocates and people living with ET, PV and MF in a recently produced MPNRF digital report MPN IMPACT@21 featuring the foundation’s impact on MPN research, clinical treatments, biopharma drug development, and most importantly MPN patients.

We invite you to read how far we have come as a community dedicated to MPN answers, and about how the foundational research driven by the MPNRF supports the next chapter of our collective story − as it drives a bold commitment to find and fund global pioneers studying innovative approaches to new MPN therapies, disease progression and prevention.

View the IMPACT@21 report here: https://www.mpnresearchfoundation.org/impact/